s16402
NM_001029851.2
NM_001029852.2
NM_001029853.2
NM_001029854.2
NM_003719.3
XM_005248621.4
XM_005248623.4
XM_005248624.4
XM_006714725.3
XM_006714726.3
XM_011543699.2
XM_011543700.2
XM_011543701.2
XM_011543702.2
XM_011543703.2
XM_011543704.2
XM_017010003.1
XM_017010004.1
XM_017010005.1
XM_017010006.1
XM_017010007.1
XM_017010008.1
13%(+/-1% mRNA remaining)(HeLa cell line) [TaqMan® Assay ID: Hs00405493_m1]
HeLa cells were reverse transfected with 5nM gene-specific Silencer® Select siRNA or 5nM Silencer® Select Negative Control #2 siRNA. 48 hours post-transfection, gene expression analysis was performed using the TaqMan® Gene Expression Cells-to-CT Kit and appropriate TaqMan® Gene Expression Assays. 18S rRNA was used as an endogenous control. Validation results are expressed as average percent mRNA remaining, relative to Negative Control siRNA-treated samples, along with the standard deviation of multiple independent experiments.